In this study, we aimed to evaluate the potential of boron supplementation (as BA) in inhibiting glioblastoma growth in a xenograft animal model, specifically assessing its role as a CMPK2 inhibitor, and contributing to the emerging interest in CMPK2 as a therapeutic target in GBM. Here, CMPK2 is linked to glioblastoma.